Mihailo Stjepanovic

28PUBLICATIONS
75CO-AUTHORS
PharmacogenomicsEpidemiological modellingCondensed matter characterisation technique developmentChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 15, 2026
Association of PDGFRB, VEGFR2, and TGFB1 Gene Polymorphisms with Nintedanib Efficacy and Adverse Effects in Patients with Progressive Pulmonary Fibrosis.

|Jun 26, 2026
Discharge Practices After Hospitalization for COPD Exacerbations: A Physician Survey and SWOT Analysis.

|May 04, 2026
Early Functional Impairment in Smokers with CT-Detected Emphysema: Spirometry Provides Complementary Physiological Information in Lung Cancer Screening.

|Apr 14, 2026
Real-World Comparison of PD-1 and PD-L1 Inhibitor Monotherapy in Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression.

Filip Marković, Zlatan Bojić, Mihailo Stjepanović

|Feb 26, 2026
Immune-Related Thyroid Dysfunction in PD-L1 High Non-Oncogene-Addicted NSCLC Treated with First-Line Pembrolizumab: Incidence, Timing, and Predictive Impact.

Filip Marković, Mihailo Stjepanović, Milica Kontić

|Jan 28, 2026
Comparison of the Efficacy of Pirfenidone and Nintedanib in the Treatment of Patients with Idiopathic Pulmonary Fibrosis-A Single-Center Experience.

Nikola Trboljevac, Sanja Dimic-Janjic, Milica Kontic

Pageof 5

Frequent Collaborators

8 joint publications

Spasoje Popevic

8 joint publications

Filip Markovic

8 joint publications

Sanja Dimic-Janjic

7 joint publications

Jelena Jankovic